Rivaroxaban takes off as alternative to warfarinROCKET AF trial suggests drug offers more user-friendly anticoagulation in atrial fibrillation Rosiglitazone: new Canadian restrictionsHealth Canada has issued new usage restrictions for rosiglitazone-containing products. Concomitant PPIs and antiplatelet agents OK Huge Canadian trial backs cardiac resynchronization therapy Combined ICD-CRT device cuts mortality and heart failure hospitalizations Pharmacy BP screening lowers hospitalizations Ontario’s Cardiovascular Health Awareness Program targeted community-dwelling seniors Cardiac imaging linked to cancer Study supports continued efforts to lower patients’ exposure to ionizing radiation Chest closure aid is just super Sternotomy patients experience less pain and disability when ‘Kryptonite’ adhesive is used Oral contraceptives may stiffen the arteries European score yields mixed results in Canadian trial Guidelines highlight cutting-edge AF treatments Role of recently approved drugs outlined in new atrial fibrillation recommendations First Previous 73 74 75 76 77 Next Last
